{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T23:11:45Z","timestamp":1774566705965,"version":"3.50.1"},"reference-count":92,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2000,6,1]],"date-time":"2000-06-01T00:00:00Z","timestamp":959817600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2000,6,1]],"date-time":"2000-06-01T00:00:00Z","timestamp":959817600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,18]],"date-time":"2013-07-18T00:00:00Z","timestamp":1374105600000},"content-version":"vor","delay-in-days":4795,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2000,6]]},"DOI":"10.1053\/rmed.2000.0806","type":"journal-article","created":{"date-parts":[[2002,9,19]],"date-time":"2002-09-19T10:55:08Z","timestamp":1032432908000},"page":"612-621","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial)"],"prefix":"10.1053","volume":"94","author":[{"given":"L.","family":"BJERMER","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"BISGAARD","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"BOUSQUET","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.M.","family":"FABBRI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"GREENING","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"HAAHTELA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.T.","family":"HOLGATE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"PICADO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.A.","family":"LEFF","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/rmed.2000.0806_RF1","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1183\/09031936.93.05050601","volume":"5","year":"1992","journal-title":"Eur Respir J"},{"key":"10.1053\/rmed.2000.0806_RF2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1398-9995.1992.tb05036.x","volume":"47","year":"1992","journal-title":"Allergy"},{"key":"10.1053\/rmed.2000.0806_RF3","unstructured":"Global Initiative for Asthma. Global strategy for asthma management and prevention, Washington, DC, National Heart, Lung, and Blood Institute, 1995"},{"key":"10.1053\/rmed.2000.0806_RF4","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1164\/ajrccm\/146.3.547","article-title":"Effects of 22 months of treatment with inhaled corticosteroids and\/or beta-2-agonists on lung function, airway responsiveness, and symptoms in children with asthma","volume":"146","author":"Van Essen-Zandvliet","year":"1992","journal-title":"Am Rev Respir Dis"},{"key":"10.1053\/rmed.2000.0806_RF5","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1056\/NEJM199409153311103","article-title":"Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma","volume":"331","author":"Haahtela","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1053\/rmed.2000.0806_RF6","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1164\/ajrccm\/141.1.21","article-title":"The long term effects of nedocromil sodium and beclomethasone dipropionate on bronchial responsiveness to methacholine in nonatopic asthma subjects","volume":"141","author":"Bel","year":"1990","journal-title":"Am Rev Respir Dis"},{"key":"10.1053\/rmed.2000.0806_RF7","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1164\/ajrccm\/142.4.832","article-title":"Effect of long term treatment with an inhaled corticosteroid (budesonide) on airways hyperresponsiveness and clinical asthma in nonsteroid-dependent asthmatics","volume":"142","author":"Juniper","year":"1990","journal-title":"Am Rev Respir Dis"},{"key":"10.1053\/rmed.2000.0806_RF8","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1136\/thx.48.8.817","article-title":"Comparison of fluticasone propionate with beclomethasone dipropionate in moderate to severe asthma treatment for one year","volume":"48","author":"Fabbri","year":"1993","journal-title":"Thorax"},{"key":"10.1053\/rmed.2000.0806_RF9","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1164\/ajrccm.149.4.8143061","article-title":"Effect of oral prednisone on airway inflammatory mediators in atopic asthma","volume":"149","author":"Dworski","year":"1994","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1053\/rmed.2000.0806_RF10","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/0091-6749(77)90051-3","article-title":"A graded dose assessment of the efficacy of beclomethasone dipropionate aerosol for severe chronic asthma","volume":"59","author":"Toogood","year":"1977","journal-title":"J Allergy Clin Immunol"},{"key":"10.1053\/rmed.2000.0806_RF11","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1398-9995.1988.tb00415.x","article-title":"A double-blind dose response study of budesonide by inhalation in patients with bronchial asthma","volume":"43","author":"Johansson","year":"1988","journal-title":"Allergy"},{"key":"10.1053\/rmed.2000.0806_RF12","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S0140-6736(73)90788-5","article-title":"Aerosol beclomethasone diproprionate and budesonide in the management of asthma","volume":"2","author":"Gaddie","year":"1973","journal-title":"Lancet"},{"key":"10.1053\/rmed.2000.0806_RF13","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1398-9995.1989.tb00457.x","article-title":"Comparison of dose-response effects of inhaled beclomethasone diproprionate and budesonide in the management of asthma","volume":"44","author":"Boe","year":"1989","journal-title":"Allergy"},{"key":"10.1053\/rmed.2000.0806_RF14","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/j.1552-4604.1998.tb04463.x","article-title":"Inflammation, inflammatory mediators, and mediator antagonists in asthma","volume":"38","author":"Lazarus","year":"1998","journal-title":"J Clin Pharmacol"},{"key":"10.1053\/rmed.2000.0806_RF15","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0002-9343(99)80404-5","article-title":"Adverse effects of inhaled corticosteroids","volume":"1998","author":"Hanania","year":"1995","journal-title":"Am J Med"},{"key":"10.1053\/rmed.2000.0806_RF16","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1164\/ajrccm.153.6.8665030","article-title":"Issues in the use of inhaled glucocorticoids","volume":"153","author":"Kamada","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1053\/rmed.2000.0806_RF17","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1056\/NEJM199711133372001","article-title":"Effect of inhaled formoterol and budesonide on ecacerbations of asthma","volume":"337","author":"Pauwels","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1053\/rmed.2000.0806_RF18","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0140-6736(94)92996-3","article-title":"Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid","volume":"344","author":"Greening","year":"1994","journal-title":"Lancet"},{"key":"10.1053\/rmed.2000.0806_RF19","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1164\/ajrccm.153.5.8630590","article-title":"Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids","volume":"153","author":"Woolcock","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1053\/rmed.2000.0806_RF20","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2500\/108854199778553028","article-title":"Concurrent use of salmeterol with inhaled corticosteroids is more effective than inhaled corticosteroid dose increases","volume":"20","author":"Murray","year":"1999","journal-title":"Allergy Asthma Proc"},{"key":"10.1053\/rmed.2000.0806_RF21","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1378\/chest.108.5.1235","article-title":"Rapid onset of tolerance to the bronchoprotective effects of salmeterol","volume":"108","author":"Bhagat","year":"1995","journal-title":"Chest"},{"key":"10.1053\/rmed.2000.0806_RF22","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1056\/NEJM199210223271703","article-title":"Long-term effects of a long-acting beta 2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma","volume":"327","author":"Cheung","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1053\/rmed.2000.0806_RF23","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1136\/thx.50.5.497","article-title":"Subsensitivity of bronchodilator and systemic beta 2 adrenoceptor responses after regular twice daily treatment with eformoterol dry powder in asthmatic patients","volume":"50","author":"Newnham","year":"1995","journal-title":"Thorax"},{"key":"10.1053\/rmed.2000.0806_RF24","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0954-6111(94)90042-6","article-title":"Reduced protection against exercise induced bronchoconstriction after chronic dosing with salmeterol","volume":"88","author":"Ramage","year":"1994","journal-title":"Respir Med"},{"key":"10.1053\/rmed.2000.0806_RF25","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1056\/NEJM199210223271704","article-title":"Tolerance to the nonbronchodilator effects of inhaled beta 2-agonists in asthma","volume":"327","author":"O'Connor","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1053\/rmed.2000.0806_RF26","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/0140-6736(93)92695-P","article-title":"Regular inhaled salbutamol and airway responsiveness to allergen","volume":"342","author":"Cockcroft","year":"1993","journal-title":"Lancet"},{"key":"10.1053\/rmed.2000.0806_RF27","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1164\/ajrccm.154.6.8970342","article-title":"An inhaled glucocorticoid does not prevent tolerance to the bronchoprotective effect of a long-acting inhaled\u03b22 -agonist","volume":"154","author":"Yates","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1053\/rmed.2000.0806_RF28","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1378\/chest.109.4.953","article-title":"Inhaled corticosteroids do not prevent the development of tolerance to the bronchoprotective effects of salmeterol","volume":"109","author":"Kalra","year":"1996","journal-title":"Chest"},{"key":"10.1053\/rmed.2000.0806_RF29","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1542\/peds.99.5.655","article-title":"Tolerance to the bronchoprotective effect of salmeterol in adolescents with exercise induced asthma using concurrent inhaled glucocorticosteroid treament","volume":"99","author":"Simons","year":"1997","journal-title":"Pediatrics"},{"key":"10.1053\/rmed.2000.0806_RF30","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1164\/ajrccm.158.3.9802069","article-title":"Potential masking effect of salmeterol on airway inflammation in asthma","volume":"158","author":"McIvor","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1053\/rmed.2000.0806_RF31","doi-asserted-by":"crossref","first-page":"487","DOI":"10.7326\/0003-4819-130-6-199903160-00005","article-title":"Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. A randomized, controlled trial","volume":"130","author":"Malmstrom","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1053\/rmed.2000.0806_RF32","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1001\/archinte.158.11.1213","article-title":"Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma. A multicenter, randomized, double-blind trial","volume":"158","author":"Reiss","year":"1998","journal-title":"Arch Intern Med"},{"key":"10.1053\/rmed.2000.0806_RF33","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1001\/jama.279.15.1181","article-title":"Montelukast for chronic asthma in 6- to 14-year-old children: a randomized, double-blind trial. Pediatric Montelukast Study Group","volume":"279","author":"Knorr","year":"1998","journal-title":"JAMA"},{"key":"10.1053\/rmed.2000.0806_RF34","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1183\/09031936.98.11061232","article-title":"Montelukast, a potent leukotriene receptor antagonist, causes dose-related improvements in chronic asthma","volume":"11","author":"Noonan","year":"1998","journal-title":"Eur Respir J"},{"key":"10.1053\/rmed.2000.0806_RF35","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1056\/NEJM199807163390302","article-title":"Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction","volume":"339","author":"Leff","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1053\/rmed.2000.0806_RF36","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0091-6749(99)70322-2","article-title":"Montelukast versus salmeterol in patients with asthma and exercise-induced bronchoconstriction","volume":"104","author":"Villaran","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"10.1053\/rmed.2000.0806_RF37","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0090-6980(95)00156-5","article-title":"Effect of leukotriene C4 exposure on ciliated cells of the nasal mucosa","volume":"51","author":"Hisamatsu","year":"1996","journal-title":"Prostaglandins"},{"key":"10.1053\/rmed.2000.0806_RF38","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/0140-6736(93)91073-U","article-title":"Leukotriene E4 and granulocytic infiltration into asthmatic airways","volume":"341","author":"Laitinen","year":"1993","journal-title":"Lancet"},{"key":"10.1053\/rmed.2000.0806_RF39","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1046\/j.1365-2222.1999.00711.x","article-title":"Anti-inflammatory mechanisms of leukotriene modulators","volume":"29","author":"Diamant","year":"1999","journal-title":"Clin Exp Allergy"},{"key":"10.1053\/rmed.2000.0806_RF40","first-page":"S419","article-title":"Leukotriene antagonism decreases endothelin-1 release during airway inflammation","volume":"12","author":"Finsnes","year":"1998","journal-title":"Eur Resp J"},{"key":"10.1053\/rmed.2000.0806_RF41","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1164\/ajrccm\/147.6_Pt_1.1472","article-title":"Differential effects of fluticasone proprionate on allergen-evoked bronchoconstriction and increased urinary leukotriene E4 excretion","volume":"147","author":"O'Shaughnessy","year":"1993","journal-title":"Am Rev Respir Dis"},{"key":"10.1053\/rmed.2000.0806_RF42","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1034\/j.1399-3003.1999.14a04.x","article-title":"Montelukast reduces airway eosinophilic inflammation in asthma: a randomized, controlled trial","volume":"14","author":"Pizzichini","year":"1999","journal-title":"Eur Respir J"},{"key":"10.1053\/rmed.2000.0806_RF43","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1164\/ajrccm.160.4.9903004","article-title":"NO in exhaled air of asthmatic children is reduced by the leukotriene receptor antagonist montelukast","volume":"160","author":"Bisgaard","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1053\/rmed.2000.0806_RF44","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1164\/ajrccm.160.6.9803042","article-title":"Montelukast added to inhaled beclomethasone in treatment of asthma","volume":"160","author":"Laviolette","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1053\/rmed.2000.0806_RF45","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1136\/thx.52.1.45","article-title":"Effects of montelukast (MK-0476); a potent cysteinyl leukotriene receptor antagonist, on bronchodilation in asthmatic subjects treated with and without inhaled corticosteroids [see comments]","volume":"52","author":"Reiss","year":"1997","journal-title":"Thorax"},{"key":"10.1053\/rmed.2000.0806_RF46","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/0140-6736(91)91709-4","article-title":"Lung function improvement in asthma with a cysteinyl-leukotriene receptor antagonist","volume":"337","author":"Hui","year":"1991","journal-title":"Lancet"},{"key":"10.1053\/rmed.2000.0806_RF47","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0022-3476(79)80075-X","article-title":"Ventilatory functions of normal children and young adults \u2014 Mexican-American, White, Black","volume":"95","author":"Hsu","year":"1979","journal-title":"Spirometry J Pediatr"},{"key":"10.1053\/rmed.2000.0806_RF48","first-page":"659","article-title":"Reference spirometric values using techniques and equipment that meet ATS recommendations","volume":"123","author":"Crapo","year":"1981","journal-title":"Am Rev Respir Dis"},{"key":"10.1053\/rmed.2000.0806_RF49","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1136\/thx.47.2.76","article-title":"Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials","volume":"47","author":"Juniper","year":"1992","journal-title":"Thorax"},{"key":"10.1053\/rmed.2000.0806_RF50","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/S0091-6749(99)70182-X","article-title":"Comparison of inhaled salmeterol and oral zafirlukast in patients with asthma","volume":"103","author":"Busse","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"10.1053\/rmed.2000.0806_RF51","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S0091-6749(98)70054-5","article-title":"A placebo-controlled, dose-ranging study of montelukast, a cysteinyl leukotriene-receptor antagonist","volume":"102","author":"Altman","year":"1998","journal-title":"J Allergy Clin Immunol"},{"key":"10.1053\/rmed.2000.0806_RF52","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S0009-9236(97)90051-5","article-title":"Dose-related protection of exercise bronchoconstriction by montelukast, a cysteinyl leukotriene-receptor antagonist, at the end of a once-daily dosing interval","volume":"62","author":"Bronsky","year":"1997","journal-title":"Clin Pharmacol Ther"},{"key":"10.1053\/rmed.2000.0806_RF53","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1016\/S0091-6749(98)70002-8","article-title":"Inflammation in asthma: the cornerstone of the disease and target of therapy","volume":"102","author":"Busse","year":"1998","journal-title":"J Allergy Clin Immunol"},{"key":"10.1053\/rmed.2000.0806_RF54","first-page":"545","article-title":"Leukotrienes and other products of the 5-lipoxygenase pathway","volume":"323","author":"Lewis","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1053\/rmed.2000.0806_RF55","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/288484a0","article-title":"Leukotrienes are potent constrictors of human bronchi","volume":"288","author":"Dahlen","year":"1980","journal-title":"Nature"},{"key":"10.1053\/rmed.2000.0806_RF56","first-page":"368","article-title":"The effect of inhaled leukotriene D4 in humans","volume":"131","author":"Smith","year":"1985","journal-title":"Am Rev Respir Dis"},{"key":"10.1053\/rmed.2000.0806_RF57","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1056\/NEJM198608213150803","article-title":"Airway responsiveness to leukotrienes C4 and D4 and to methacholine in patients with asthma and normal controls","volume":"315","author":"Adelroth","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1053\/rmed.2000.0806_RF58","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1136\/thx.47.6.404","article-title":"Inhaled corticosteroids: benefits and risks","volume":"47","author":"Geddes","year":"1992","journal-title":"Thorax"},{"key":"10.1053\/rmed.2000.0806_RF59","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0163-7258(93)90049-J","article-title":"Clinical pharmacology of corticosteroids in bronchial asthma","volume":"55","author":"Lipworth","year":"1993","journal-title":"Pharmacol Ther"},{"key":"10.1053\/rmed.2000.0806_RF60","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1164\/ajrccm.158.1.9706048","article-title":"Addition of salmeterol versus doubling the dose of beclomethasone in children with asthma","volume":"158","author":"Verberne","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1053\/rmed.2000.0806_RF61","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1378\/chest.107.4.1116","article-title":"Are there any detrimental effects of the use of inhaled long-acting J2-agonists in the treatment of asthma","volume":"107","author":"Devoy","year":"1995","journal-title":"Chest"},{"key":"10.1053\/rmed.2000.0806_RF62","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/0140-6736(90)93098-A","article-title":"Regular inhaled beta-agonist treatment in bronchial asthma","volume":"336","author":"Sears","year":"1990","journal-title":"Lancet"},{"key":"10.1053\/rmed.2000.0806_RF63","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1136\/bmj.303.6815.1426","article-title":"Bronchodilator treatment in moderate asthma or chronic bronchitis: continuous or on-demand? A randomized controlled study","volume":"303","author":"Van Schayck","year":"1991","journal-title":"BMJ"},{"key":"10.1053\/rmed.2000.0806_RF64","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1183\/09031936.93.02040325","article-title":"Formoterol, a new long-acting bronchodilator for inhalation","volume":"2","author":"Arvidsson","year":"1989","journal-title":"Eur Respir J"},{"key":"10.1053\/rmed.2000.0806_RF65","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1164\/ajrccm\/142.3.571","article-title":"Inhaled salmeterol and salbutamol in asthmatic patients: an evaluation of asthma symptoms and the possible development of tachyphylaxis","volume":"142","author":"Ullman","year":"1990","journal-title":"Am Rev Respir Dis"},{"key":"10.1053\/rmed.2000.0806_RF66","first-page":"A272","article-title":"Tachyphylaxis of the bronchodilator and protective actions of salmeterol in asthmatics in inhaled corticosteroids","volume":"152","author":"Booth","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1053\/rmed.2000.0806_RF67","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2165\/00002018-199716050-00002","article-title":"Airway subsensitivity with long-acting beta 2-agonists. Is there cause for concern?","volume":"16","author":"Lipworth","year":"1997","journal-title":"Drug Saf"},{"key":"10.1053\/rmed.2000.0806_RF68","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1136\/thx.53.9.744","article-title":"Asthma control during long-term treatment with regular inhaled salbutamol and salmeterol","volume":"53","author":"Taylor","year":"1998","journal-title":"Thorax"},{"key":"10.1053\/rmed.2000.0806_RF69","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S1081-1206(10)63159-6","article-title":"A six-month, placebo-controlled comparison of the safety and efficacy of salmeterol or beclomethasone for persistent asthma","volume":"82","author":"Nathan","year":"1999","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1053\/rmed.2000.0806_RF70","first-page":"261","article-title":"Anti-inflammatory effects of salmeterol compared with beclomethasone in eosinophilic mild exacerbations of asthma: a randomized, placebo controlled trial","volume":"5","author":"Turner","year":"1998","journal-title":"Can Respir J"},{"key":"10.1053\/rmed.2000.0806_RF71","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1378\/chest.111.5.1249","article-title":"The effect of salmeterol on nocturnal symptoms, airway function, and inflammation in asthma","volume":"111","author":"Kraft","year":"1997","journal-title":"Chest"},{"key":"10.1053\/rmed.2000.0806_RF72","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1164\/ajrccm.150.4.7921429","article-title":"Effect of 8 weeks of treatment with salmeterol on bronchoalveolar lavage inflammatory indices in asthmatics","volume":"150","author":"Gardiner","year":"1994","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1053\/rmed.2000.0806_RF73","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1164\/ajrccm.150.5.7952550","article-title":"Partial inhibition of the early and late asthmatic response by a single dose of salmeterol","volume":"150","author":"Weersink","year":"1994","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1053\/rmed.2000.0806_RF74","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/0091-6749(92)90325-V","article-title":"A comparative study in atopic subjects with asthma of the effects of salmeterol and salbutamol on allergen-induced bronchoconstriction, increase in airway reactivity, and increase in urinary leukotriene E4 excretion","volume":"89","author":"Taylor","year":"1992","journal-title":"J Allergy Clin Immunol"},{"key":"10.1053\/rmed.2000.0806_RF75","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1159\/000236822","article-title":"Comparison of salmeterol with placebo in mild asthma: effect on peripheral blood phagocyte function and cytokine levels","volume":"105","author":"Ramage","year":"1994","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1053\/rmed.2000.0806_RF76","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1034\/j.1399-3003.1999.14b07.x","article-title":"The long-acting beta2-agonist salmeterol xinafoate: effects on airway inflammation in asthma","volume":"14","author":"Roberts","year":"1999","journal-title":"Eur Respir J"},{"key":"10.1053\/rmed.2000.0806_RF77","first-page":"455","article-title":"Steroid resistance in asthma","volume":"88","author":"Barnes","year":"1995","journal-title":"Q J Med"},{"key":"10.1053\/rmed.2000.0806_RF78","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1074\/jbc.274.2.1005","article-title":"Ligand-independent activation of the glucocorticoid receptor by beta2-adrenergic receptor agonists in primary human lung fibroblasts and vascular smooth muscle cells","volume":"274","author":"Eickelberg","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1053\/rmed.2000.0806_RF79","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1164\/ajrccm.159.1.9801007","article-title":"The effects of regular inhaled formoterol, budesonide, and placebo on mucosal inflammation and clinical indices in mild asthma","volume":"159","author":"Wallin","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1053\/rmed.2000.0806_RF80","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1056\/NEJM199711133372002","article-title":"A comparison of low-dose inhaled budesonide plus theophylline and high- dose inhaled budesonide for moderate asthma","volume":"337","author":"Evans","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1053\/rmed.2000.0806_RF81","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1081-1206(10)63471-0","article-title":"The role of theophylline in the treatment of asthma","volume":"77","author":"Kamada","year":"1996","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1053\/rmed.2000.0806_RF82","first-page":"839","article-title":"The changing role of theophylline in pediatric asthma","volume":"49","author":"Stoloff","year":"1994","journal-title":"Am Fam Physician"},{"key":"10.1053\/rmed.2000.0806_RF83","doi-asserted-by":"crossref","first-page":"12","DOI":"10.2165\/00002018-199308010-00003","article-title":"Theophylline: current thoughts on the risks and benefits of its use in asthma","volume":"8","author":"Nasser","year":"1993","journal-title":"Drug Saf"},{"key":"10.1053\/rmed.2000.0806_RF84","unstructured":"National Asthma Education and Prevention Program, Expert Panel Report II: Guidelines for the Diagnosis and Management of Asthma: NHLBI Workshop Report, Bethesda, Md, National Heart, Lung, and Blood Institute, National Institutes of Health, 1995"},{"key":"10.1053\/rmed.2000.0806_RF85","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0091-6749(81)90028-2","article-title":"A clinical trial of combined cromolyn\/beclomethasone treatment for chronic asthma","volume":"67","author":"Toogood","year":"1981","journal-title":"J Allergy Clin Immunol"},{"key":"10.1053\/rmed.2000.0806_RF86","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1136\/thx.52.12.1030","article-title":"Increased urinary excretion of LTE4 after exercise and attenuation of exercise-induced bronchospasm by montelukast, a cysteinyl leukotriene receptor antagonist","volume":"52","author":"Reiss","year":"1997","journal-title":"Thorax"},{"key":"10.1053\/rmed.2000.0806_RF87","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1164\/ajrccm.153.1.8542164","article-title":"The effect of regular inhaled albuterol on exercise-induced bronchoconstriction","volume":"153","author":"Inman","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1053\/rmed.2000.0806_RF88","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1183\/09031936.95.08091488","article-title":"Effect of regular inhaled beclomethasone on exercise and methacholine airway responses in school children with recurrent wheeze","volume":"8","author":"Freezer","year":"1995","journal-title":"Eur Respir J"},{"key":"10.1053\/rmed.2000.0806_RF89","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1136\/bmj.4.5731.337","article-title":"Exercise asthma and disodium cromoglycate","volume":"4","author":"Poppius","year":"1970","journal-title":"Br Med J"},{"key":"10.1053\/rmed.2000.0806_RF90","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0007-0971(62)80005-9","article-title":"The effect of exercise on ventilatory function in the child with asthma","volume":"56","author":"Jones","year":"1962","journal-title":"Br J Dis Chest"},{"key":"10.1053\/rmed.2000.0806_RF91","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/0091-6749(92)90099-N","article-title":"Blood eosinophil numbers and activity during 24 hours: effects of treatment with budesonide and bambuterol","volume":"90","author":"Wempe","year":"1992","journal-title":"J Allergy Clin Immunol"},{"key":"10.1053\/rmed.2000.0806_RF92","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/(SICI)1099-0496(200003)29:3<221::AID-PPUL11>3.0.CO;2-P","article-title":"Long-acting \u03b22-agonists in management of childhood asthma: a critical review of the literature","volume":"29","author":"Bisgaard","year":"2000","journal-title":"Pediatric Pulmonology"}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611100908060?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611100908060?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T10:02:12Z","timestamp":1760608932000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611100908060"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,6]]},"references-count":92,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2000,6]]}},"alternative-id":["S0954611100908060"],"URL":"https:\/\/doi.org\/10.1053\/rmed.2000.0806","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2000,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial)","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/rmed.2000.0806","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2000 Harcourt Publishers Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}